Behring Diagnostics Launches the Behring Coagulation Timer (BCT System) in the United States.FRANKFURT, Germany and CHICAGO--(HealthWire)--July 30, 1996-- Behring Diagnostics, a division of Hoechst, today announced the launch of the Behring Coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or Timer (BCT BCT Brigade Combat TeamBCT Basic Combat Training BCT Best Conventional Pollutant Control Technology (EPA) BCT Business Cards Tomorrow BCT Banque Centrale de Tunisie (Central Bank of Tunisia) (TM) System) in the United States. The BCT system is a new automated instrument for conducting clotting, chromogenic chro·mo·gen·ic adj. Of or relating to a chromogen or to chromogenesis. chromogenic (krō´mōjen´ik), adj pertaining to color production. and immunologic(a) tests in laboratory settings. Behring Diagnostics launched the system in conjunction with the opening of the American Association for Clinical Chemistry meeting in Chicago. The launch follows U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) market clearance for the instrument, which was granted to Behring Diagnostics in May 1996. Behring Diagnostics is a worldwide market leader in coagulation, enjoying a 40 percent market share in Germany and strong growth in key markets of the world. With the launch of the BCT system in the United States -- the largest coagulation market in the world estimated at U.S. $180 million -- the system is now available worldwide. The BCT system was launched throughout Europe in 1995. The coagulation market for Europe is estimated at U.S. $200 million. Behring Diagnostics offers the most comprehensive line of coagulation instruments and reagents for the in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. industry. The BCT instrument features an automatic start capability and up to 27 reagents on board, thus allowing for more than 20 tests to be run simultaneously. For convenience and sample security, primary tubes can be used on the BCT system. In addition, the instrument is extremely efficient in that it has the capability to run clotting tests as well as chromogenic tests and immunologic(a) tests in the same run. A user-friendly software program allows the technician to access key statistics including calibration data and sample identification in addition to quality control. "In coagulation, immediacy of results is critical, not only for diagnosis, but for effective patient management. Our systems help physicians to effectively manage the risks associated with coagulation disorders Coagulation Disorders Definition Coagulation disorders deal with disruption of the body's ability to control blood clotting. The most commonly known coagulation disorder is hemophilia, a condition in which patients bleed for long periods of time before ," said Klaus Kohler, Ph.D., Head of Coagulation Marketing, within the Global Marketing Organization of Behring Diagnostics. "Behring Diagnostics recognizes the need for a strong presence in the coagulation market in the United States. The availability of the BCT system here is the first step in penetrating this growth area." Behring Diagnostics, a division of Hoechst, with headquarters in Frankfurt, Germany, manufactures and markets in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic systems used by healthcare professionals in hospitals and laboratories throughout the world. The division has five business lines: the OPUS(R) business line, located in Westwood, Massachusetts; the Syva(R) business line, based in San Jose, California San Jose (IPA: /ˌsænhoʊˈzeɪ/) is the third-largest city in California, and the tenth-largest in the United States. It is the county seat of Santa Clara County. ; and plasma proteins, coagulation and microbiology/infectious diseases, three further business lines, based in Marburg, Germany. Behring Diagnostics acquired the former Syva Company in 1995. In 1995, Behring Diagnostics had consolidated net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight of DM 1.027 billion. The division employs approximately 3,000 worldwide. (a) Available outside the United States only. -0- OPUS and Syva are registered trademarks of Behringwerke AG. CONTACT: In the US: Ton Jansen ph +1 (408) 239-4477, fx +1 (408) 239-2550 Outside the US: Dr. Klaus Kohler ph +49 (69) 305 83740, fx +49 (69) 305-83782 REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion